Hims & Hers Health (HIMS) Short-term Investments (2020 - 2026)
Hims & Hers Health (HIMS) reported Short-term Investments of $528.6 million for Q1 2026, up 980.23% on a YoY basis from $48.9 million in Q1 2025, and up 51.52% sequentially from $348.9 million in Q4 2025.
Hims & Hers Health (HIMS) Short-term Investments (2020 - 2026) Analysis & Trends
Hims & Hers Health (HIMS) has 7 years of Short-term Investments data on file, last reported at $528.6 million in Q1 2026.
- For the quarter ending Q1 2026, Short-term Investments rose 980.23% year-over-year to $528.6 million; the trailing twelve-month figure through Mar 2026 stood at $528.6 million (up 980.23% YoY), and the FY2025 full-year result was $348.9 million, up 337.92% from the prior year.
- Short-term Investments grew to $528.6 million in Q1 2026, from $348.9 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $528.6 million in Q1 2026 to a low of $20.0 million in Q2 2025.
- A 5-year average of $159.1 million and a median of $132.9 million in 2022 frame the typical range for Short-term Investments.
- Across the five-year window, Short-term Investments tumbled 79.56% in 2025 and soared 980.23% in 2026, its largest moves.
- Tracing HIMS's Short-term Investments over 5 years: stood at $132.9 million in 2022, then dropped by 6.42% to $124.3 million in 2023, then plunged by 35.92% to $79.7 million in 2024, then jumped by 337.92% to $348.9 million in 2025, then surged by 51.52% to $528.6 million in 2026.
- Business Quant data shows HIMS's Short-term Investments at $528.6 million in Q1 2026, $348.9 million in Q4 2025, and $284.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Hims & Hers Health | 7.48 Bn | 6.73 Bn | 396.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 528.61 Mn |
| Dec 31, 2025 | 348.88 Mn |
| Sep 30, 2025 | 283.97 Mn |
| Jun 30, 2025 | 20.03 Mn |
| Mar 31, 2025 | 48.94 Mn |
| Dec 31, 2024 | 79.67 Mn |
| Sep 30, 2024 | 88.55 Mn |
| Jun 30, 2024 | 98.00 Mn |
| Mar 31, 2024 | 98.36 Mn |
| Dec 31, 2023 | 124.32 Mn |
| Sep 30, 2023 | 154.50 Mn |
| Jun 30, 2023 | 127.73 Mn |
| Mar 31, 2023 | 135.65 Mn |
| Dec 31, 2022 | 132.85 Mn |
| Sep 30, 2022 | 140.43 Mn |
| Jun 30, 2022 | 139.94 Mn |
| Mar 31, 2022 | 154.77 Mn |
| Dec 31, 2021 | 175.49 Mn |
| Sep 30, 2021 | 187.65 Mn |
| Jun 30, 2021 | 210.18 Mn |